aspirin and dipyridamole capsule, extended release
teva pharmaceuticals usa, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole is contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole use and major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data) . aspi
aspirin and extended-release dipyridamole capsule, extended release
golden state medical supply, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole capsules use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole capsules use and major birth defects, miscarriage, or adverse maternal or feta
aspirin and extended-release dipyridamole capsule
ani pharmaceuticals, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole use and major birth defects, miscarriage, or adverse maternal or fetal outcomes (see da
aspirin and extended-release dipyridamole capsule, extended release
micro labs limited - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin and extended-release dipyridamole capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsule is contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole capsules use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole capsules use and major birth defects, miscarriage, or adverse maternal or fetal ou
aspirin and extended - release dipyridamole capsules, 25 mg / 200 mg- aspirin and extended - release dipyridamole capsule
major pharmaceuticals - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin and extended-release dipyridamole capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole is contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-in aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. risk summary available data from published studies and postmarketing experience with aspirin and extended-release dipyridamole use during pregnancy have not identified a clear association between aspirin and extended-release dipyridamole use and major bir
aspirin tablet, coated
l&r distributors, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 81 mg - pain reliever for the temporary relief of minor aches and pains or as recommended by your doctor
aspirin tablet, film coated
l&r distributors, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 325 mg - pain reliever/fever reducer temporarily relieves: - headache - pain and fever of colds - toothache - menstrual pain - muscle pain - minor pain of arthritis
aspirin low dose- aspirin tablet, coated
l&r distributors, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 81 mg - pain reliever for the temporary relief of minor aches and pains or as recommended by your doctor
aspirin low dose- aspirin tablet, chewable
l&r distributors, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 81 mg - pain reliever for the temporary relief of minor aches and pains or as recommended by your doctor
aspirin 325 mg ec- aspirin tablet
reliable 1 laboratories llc - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 325 mg - pain reliever/fever reducer temporarily relieves - headache - menstrual pain - minor pain of arthritis - muscle pain - toothache - pain and fever of colds do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer stop use and ask a doctor if - you experience any of the following signs of stomach bleeding: • feel faint • vomit blood • have bloody or black stools • have stomach pain that does not get better - pain gets worse or lasts more than 10 days - fever gets worse or lasta more than 3 days - redness or swelling is present in the painful area - any new symptoms appear - ringing in the ears or loss of hearing occurs these could be sings of a serious condition